Drugs in the Pipeline for Gram-positive, C difficile, and Non-tuberculosis Mycobacterial Infections
June 25th 2019A look at the latest developments in drugs intended to quell gram-positive pathogens, including Clostridioides difficile and non-tuberculosis mycobacterial infections, as presented at ASM Microbe 2019.